Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is active but not recruiting in the United States. It is testing ANAVEX3-71 for schizophrenia.
In United StatesThis study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.
In United StatesThis study is completed in the United States. It is testing aripiprazole for depression.
In United StatesThis study is completed in the United States. It is testing aripiprazole for depression.
In United StatesThis study is completed in the United States. It is testing aripiprazole Lauroxil (Also Known for schizophrenia.
In United StatesThis study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
In United StatesThis study is completed in the United States. It is testing aripiprazole Lauroxil or Paliperidone Palmitate for schizophrenia.
In United StatesThis study was terminated in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In United StatesThis study is completed in the United States, in Australia, in Belgium, .... It is testing aticaprant for depression.
In United StatesThis study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
In United StatesThis study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.